Back to Job Search
Expired
  • Salary: Up to £40,000 D.o.E. plus benefits
  • Job Type:Permanent

Posted almost 7 years ago

  • Contact: James Hume
  • Contact Email: james.hume@nextphaserecruitment.com
  • Contact Phone: +44 1403 216200
  • Duration: n/a
  • Start Date: ASAP
  • Job Ref: 15365 JH
  • Job Title: Senior Scientist – Bioproduction
  • Salary: Up to £40,000 D.o.E. plus benefits
  • Location: Oxford
  • ***NEW ROLES RELEASED***
  • Excellent Opportunity to Join a Cutting Edge Synthetic Biology Company Developing Solutions for the Cell and Gene Therapy industries.
  • A Unique Role that has Influence on the Continued Growth of the Company and Further Development if Their Unique Platform Technology.

Are you interested at being at the cutting edge of Synthetic Biology research?

Do you have a proven track record of excellent research to genetically engineer mammalian Cell Lines?

Are you a creative and rigorous thinker who can use your initiative to solve problems?

Then this is the opportunity for you!

Job Summary:

This is a truly exciting opportunity to join a fast developing biotech who are pioneers in the use of synthetic biology and its application to transform the discovery, development and manufacture of biologics, cell & gene therapies.  Based in state-of-the-art laboratories near Oxford they are at the cutting edge of research in this field, which has huge potential to deliver solutions for the production of complex, high value products.  They need to recruit a Senior Scientist who can lead and deliver research projects in partnership with commercial organisations, alongside internal platform development projects that are crucial to the continued growth of the company. 

The Company

The company are at the cutting edge of the exciting field of synthetic biology after developing their unique platform which enables them to offer solutions to the discovery, development and manufacture of biologics, cell & gene therapies.  They currently offer a range of custom and platform services, specialising in DNA design, optimisation of protein and viral expression systems, and cell line development technologies. 

A strong focus is placed on R&D activities and further developing platform technologies, as supported by the recent receipt of multiple grants awards from Innovate UK. 

The Opportunity:

As a Senior Scientist you will be a leading member of the laboratory team with the responsibility for planning and executing both internal and commercial research & development projects.  The projects will focus on genetically engineering viral expression and delivery systems with a focus on Lentivirus, Retrovirus and rAAV. Experience with multiple viral systems, and handling mammalian cell lines, including isolating and working with primary cells would be essential. 

This company has fantastic growth potential meaning there will be opportunities to further your career, and to contribute significantly in bringing new products and services to the market. 

Desired Skills and Experience:

They are looking for a creative thinking scientist who has a PhD or equivalent in a relevant field that has been followed by experience in a commercial environment.  You will need to have experience of working in a multidisciplinary industrial environment with the responsibility for the delivery of results and external communication with clients and / or third parties.  With demonstrable prior experience for the delivery of results and the ability to use your own initiative to work autonomously.

Keywords

Virus, viral, viral vector, bioprocessing, upstream, downstream, GMP, in vivo, ex vivo, gene therapy, cell therapy, vector, analytical development, scale up, bioprocess, biologics, bacteria, mammalian, human, primary, cell culture, industrialisation, commercialisation, engineering, bioreactor, chromatography, filtration, separation, purification, assay, characterisation, in process, control, biochemistry, molecular biology, cell line, mammalian, cell culture, synthetic biology, flow cytometry, recombinant protein, antibody, retrovirus, lentivirus, protein expression, robot, automation, bioreactor.